Surge Raises $2.6M, Secures Exclusive Licensing Agreement with Stanford to Make Surgeries Safer

Surge's technology predicts postoperative complications SAN FRANCISCO, Sept. 23, 2022 /PRNewswire/ -- Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated to high-potential technology startups, and Boutique Venture...

Click to view original post